Sublingual misoprostol versus standard surgical care for treatment of incomplete abortion in five sub-Saharan African countries

BMC Pregnancy and Childbirth

Volumn 12, Issue , 2012, Pages

  Shochet, Tara ^a   Diop, Ayisha ^a   Gaye, Alioune ^b   Nayama, Madi ^c   Sall, Aissata B ^d   Bukola, Fawole ^e   Blandine, Thieba ^f   Abiola, Okunlola M ^e   Dao, Blami ^g   Olayinka, Ogunbode ^e   Winikoff, Beverly ^a  

^a GYNUITY HEALTH PROJECTS   (United States)

^b Centre de Sante le Roi Baudouin   (Senegal)

^c Issaka Gazoby Maternity Hospital   (Niger)

^d Cheikh Zayed Hospital   (Mauritania)

^e UNIVERSITY OF IBADAN   (Nigeria)

^f CENTRE HOSPITALIER UNIVERSITAIRE YALGADO OUÉDRAOGO   (Burkina Faso)

^g Centre Hospitalier National Souro Sanou   (Burkina Faso)

Author keywords

Incomplete abortion; Manual vacuum aspiration (MVA); Misoprostol; Post abortion care (PAC)

Indexed keywords

MISOPROSTOL;

ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; ARTICLE; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; FOLLOW UP; HUMAN; INCOMPLETE ABORTION; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; PREGNANCY; TREATMENT OUTCOME; VAGINA BLEEDING;

ABORTIFACIENT AGENTS, NONSTEROIDAL; ABORTION, INCOMPLETE; ADMINISTRATION, SUBLINGUAL; ADOLESCENT; ADULT; BURKINA FASO; DILATATION AND CURETTAGE; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; MAURITANIA; MIDDLE AGED; MISOPROSTOL; NIGER; NIGERIA; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PREGNANCY; PREGNANCY TRIMESTER, FIRST; SENEGAL; TREATMENT OUTCOME; VACUUM CURETTAGE; YOUNG ADULT;

EID: 84868707348     PISSN: None     EISSN: 14712393     Source Type: Journal    
DOI: 10.1186/1471-2393-12-127     Document Type: Article

References (16)

1. World Health Organization (WHO) Unsafe abortion: Global and regional estimates of the incidence of unsafe abortion and associated mortality in 2008 2011, Geneva: WHO, 6, World Health Organization (WHO).
2. Weeks A, Alia G, Blum J, Winikoff B, Ekwaru P, Durocher J, Mirembe F. A randomized trial of misoprostol compared with manual vacuum aspiration for incomplete abortion. Obstet Gynecol 2005, 106(3):540-547. 10.1097/01.AOG.0000173799.82687.dc, 16135584.
3. Shwekerela B, Kalumuna R, Kipingili R, Mashaka N, Westheimer E, Clark W, Winikoff B. Misoprostol for treatment of incomplete abortion at the regional hospital level: Results from Tanzania. BJOG 2007, 114(11):1363-1367. 10.1111/j.1471-0528.2007.01469.x, 17803714.
4. Dao B, Blum J, Thieba B, Raghavan S, Ouedraego M, Lankoande J, Winikoff B. Is misoprostol a safe, effective and acceptable alternative to manual vacuum aspiration for post-abortion care? Results from a randomized trial in Burkina Faso, West Africa. BJOG 2007, 114(11):1368-1375. 10.1111/j.1471-0528.2007.01468.x, 17803715.
5. Bique C, Ustá M, Debora B, Chong E, Westheimer E, Winikoff B. Comparison of misoprostol and manual vacuum aspiration for the treatment of incomplete abortion. Int J Gynaecol Obstet 2007, 98(3):222-226. 10.1016/j.ijgo.2007.05.003, 17610879.
6. Blum J, Winikoff B, Gemzell-Danielsson K, Ho PC, Schiavon R, Weeks A. Treatment of incomplete abortion and miscarriage with misoprostol. Int J Gynaecol Obstet 2007, 99(Suppl 2):S186-S189.
7. Diop A, Raghavan S, Rakotovao JP, Comendant R, Blumenthal PD, Winikoff B. Two routes of administration for misoprostol in the treatment of incomplete abortion: a randomized clinical trial. Contraception 2009, 79(6):456-462. 10.1016/j.contraception.2008.11.016, 19442782.
8. Dabash R, Ramadan MC, Darwish E, Hassanein N, Blum J, Winikof B. A randomizes controlled trial of 400-μg sublingual misoprostol versus manual vacuum aspiration for the treatment of incomplete abortion in two Egyptian hospitals. Int J Gynaecol Obstet 2010, 111(2):131-135. 10.1016/j.ijgo.2010.06.021, 20801444.
9. Taylor J, Diop A, Blum J, Dolo O, Winikoff B. Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana. Int J Gynaecol Obstet 2011, 112(1):40-44. 10.1016/j.ijgo.2010.08.022, 21122848.
10. Akin A, Blum J, Ozalp S, Onderoǧlu L, Kirca U, Bilgili N, Koçoǧlu G, Philip N, Winikoff B. Results and lessons learned from a small medical abortion clinical study in Turkey. Contraception 2004, 70(5):401-406. 10.1016/j.contraception.2004.05.005, 15504380.
11. Akin A, Dabash R, Dilbaz B, Aktün H, Dursun P, Kiran S, Aksan G, Doǧan B, Winikoff B. Increasing women's choices in medical abortion: a study of misoprostol 400 microg swallowed immediately or held sublingually. Eur J Contracept Reprod Health Care 2009, 14(3):169-175. 10.1080/13625180902916020, 19565414.
12. Grossman D, Ellertson C, Grimes DA, Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol 2004, 103(4):738-745. 10.1097/01.AOG.0000115511.14004.19, 15051567.
13. Fjerstad M. Figuring out follow-up. Mifematters PPFA/CAPS 2006, 13:2-3.
14. American College of Obstetricians and Gynecologists Misoprostol for postabortion care. ACOG Committee Opinion No. 427. Obstet Gynecol 2009, 113:465-468. American College of Obstetricians and Gynecologists.
15. World Health Organization Safe abortion: Technical and policy guidance for health systems 2012, Geneva: WHO, 2, World Health Organization.
16. World Health Organization (WHO) WHO model list of essential medicines 2010, Geneva: WHO, 16, World Health Organization (WHO).